152 related articles for article (PubMed ID: 21271335)
1. Ring fibers visualized by electron microscopy in a Japanese patient with malignant hyperthermia.
Kitagawa Y; Sato J; Kuriyama M; Sano K; Hashimoto K
Odontology; 2011 Jan; 99(1):101-104. PubMed ID: 21271335
[TBL] [Abstract][Full Text] [Related]
2. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
Brandom BW; Muldoon SM
Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
[TBL] [Abstract][Full Text] [Related]
3. Suxamethonium, masseter spasm and later malignant hyperthermia.
Ramirez JA; Cheetham ED; Laurence AS; Hopkins PM
Anaesthesia; 1998 Nov; 53(11):1111-6. PubMed ID: 10023282
[TBL] [Abstract][Full Text] [Related]
4. Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.
Swan H; Laitinen PJ; Toivonen L
Anesth Analg; 2004 Aug; 99(2):435-7, table of contents. PubMed ID: 15271719
[TBL] [Abstract][Full Text] [Related]
5. Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
Garrido S; Fraga M; Martín MJ; Belda J
Anesthesiology; 1999 Apr; 90(4):1208-9. PubMed ID: 10201695
[No Abstract] [Full Text] [Related]
6. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
[No Abstract] [Full Text] [Related]
7. No response to trigger agents in a malignant hyperthermia-susceptible patient.
Claxton BA; Cross MH; Hopkins PM
Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
[TBL] [Abstract][Full Text] [Related]
8. Anesthetic drugs and onset of malignant hyperthermia.
Visoiu M; Young MC; Wieland K; Brandom BW
Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
[TBL] [Abstract][Full Text] [Related]
9. Fatal malignant hyperthermia--delayed onset and atypical course.
Karger B; Teige K
Forensic Sci Int; 2002 Oct; 129(3):187-90. PubMed ID: 12372688
[TBL] [Abstract][Full Text] [Related]
10. [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
Helf D; Schneiderbanger D; Markus CK; Johannsen S; Schuster F
Anaesthesist; 2018 Apr; 67(4):275-279. PubMed ID: 29480319
[TBL] [Abstract][Full Text] [Related]
11. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Ta TA; Pessah IN
Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
[TBL] [Abstract][Full Text] [Related]
12. Junctional membrane Ca
Cully TR; Choi RH; Bjorksten AR; Stephenson DG; Murphy RM; Launikonis BS
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8215-8220. PubMed ID: 30038012
[TBL] [Abstract][Full Text] [Related]
13. Difficult diagnosis of malignant hyperthermia during laparoscopic surgery.
Freiermuth D; Poblete B; Singer M; Konrad CJ; Girard T
Eur J Anaesthesiol; 2013 Oct; 30(10):635-8. PubMed ID: 23736090
[No Abstract] [Full Text] [Related]
14. Human malignant hyperthermia associated with desflurane anesthesia.
Allen GC; Brubaker CL
Anesth Analg; 1998 Jun; 86(6):1328-31. PubMed ID: 9620529
[No Abstract] [Full Text] [Related]
15. Malignant hyperthermia.
Halliday NJ
J Craniofac Surg; 2003 Sep; 14(5):800-2. PubMed ID: 14501352
[TBL] [Abstract][Full Text] [Related]
16. Malignant hyperthermia: pharmacology of triggering.
Hopkins PM
Br J Anaesth; 2011 Jul; 107(1):48-56. PubMed ID: 21624965
[TBL] [Abstract][Full Text] [Related]
17. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
[TBL] [Abstract][Full Text] [Related]
18. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families.
Kaufmann A; Kraft B; Michalek-Sauberer A; Weindlmayr M; Kress HG; Steinboeck F; Weigl LG
Anesth Analg; 2012 May; 114(5):1017-25. PubMed ID: 22415532
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia and its implications in general dentistry.
Reifenstahl EF; Rowshan HH
Gen Dent; 2009; 57(3):242-6; quiz 247-8. PubMed ID: 19819813
[TBL] [Abstract][Full Text] [Related]
20. Masseter muscle rigidity and the role of DNA analysis to confirm malignant hyperthermia susceptibility.
Hudig K; Pollock N; Bulger T; Machon RG; Woodhead A; Schiemann AH; Stowell KM
Anaesth Intensive Care; 2019 Jan; 47(1):60-68. PubMed ID: 30864471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
